Connect with us

Cannabis

Medical Cannabis Market Size, Share, Growth Analysis, Global Trends, Industry Overview, Regional Forecast by 2027|Top Leaders-Aurora Cannabis, Aphria Medical Cannabis, MedReleaf Corp, Medical Marijuana: Says DBMR Analyst

GlobeNewswire

Published

on

PUERTO RICO, July 14, 2020 (GLOBE NEWSWIRE) — DBMR recently introduced Global Medical Cannabis Market Size, Share, Growth, Industry Trends and Forecast to 2027 study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2027. Medical Cannabis Market Research Report explores analyses of historical data along with Market Size, Share, Growth, Demand, and Revenue of the global medical cannabis and estimates the future trend of medical cannabis market on the basis of this detailed study. The study shares Medical Cannabis Market performance both in terms of volume and revenue and this factor which is useful & helpful to the business. This report also provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. The growth of the Medical Cannabis market was mainly driven by the increasing R&D spending across the world, however latest COVID scenario and economic slowdown have changed complete market dynamics.
DBMR Analyses the Medical Cannabis Market to account to USD 82.19 billion by 2027 growing at a CAGR of 20.25% in the forecast period. Increasing awareness about the advantages of cannabis is expected to create new opportunity for the market.Get Exclusive Sample (350 Pages PDF) Report along with Tables and Figure and Pie Chart @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-cannabis-marketGlobal Medical Cannabis Market Report 2020 (value and volume) by company, regions, product types, end industries, history data and estimate data. In addition, Report contains a comprehensive analysis of the important segments like market opportunities, import/export details, market dynamics, key manufacturers, growth rate, and key regions. This report focuses on the Medical Cannabis in the Global market, especially in the United States, Europe, China, Japan, South Korea, North America, India. Medical Cannabis Market report categorizes the market based on manufacturers, regions, type, and application. Medical Cannabis Market reports offer a detailed assessment of the Medical Cannabis including enabling technologies, current market situation, market assumptions, restraining factors.The Global Medical Cannabis Market SWOT is provided for the international markets including progress trends, competitive landscape breakdown, and key in regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed.Understand Post COVID-19 Impact and Opportunities of Medical Cannabis Market @ https://www.databridgemarketresearch.com/covid-19-impact/global-medical-cannabis-marketA collective analysis on Medical Cannabis offers an exhaustive study supported current trends influencing this vertical throughout assorted geographies. Key information regarding market size, market share, statistics, application, and revenue is within the research to develop an ensemble prediction. Additionally, this research offers an in-depth competitive analysis that specializes in business outlook emphasizing expansion strategies accepted by market majors.The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and helps in understanding the facts much better.Visit here to In-Depth Research study Report https://www.databridgemarketresearch.com/reports/global-medical-cannabis-market Top Key Players of Medical Cannabis Market Report areCanopy Growth CorporationGW Pharmaceuticals plc.Aurora CannabisAphria Medical CannabisMedReleaf CorpCanniMed LtdUnited CannabisThe Peace Naturals Project IncMedical Marijuana, IncBOL PharmaCresco LabsAccess Full Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-medical-cannabis-marketThe report also focuses on global major leading industry players of Global Medical Cannabis market providing information such as company profiles, product picture and specification, price, capacity, cost, production, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. With tables and figures helping analyze worldwide Global Medical Cannabis market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. The Global Medical Cannabis market development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.Key Segmentation of Medical Cannabis Market:Medical Cannabis Market Segments by SpeciesCannabis IndicaSativaHybridMedical Cannabis Market Segments by DerivativesCannabidiol (CBD)Tetrahydrocannabinol (THC)OthersMedical Cannabis Market Segments by ApplicationPharmaceutical IndustryResearch and Development Centers OtherMedical Cannabis Market Segments by Route of AdministrationOral SolutionsCapsulesSmokingVaporizersTopicalsOthersMedical Cannabis Market Segments by GeographyNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaFor More Information or Query and Looking for Customization click on below link and drop message @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-medical-cannabis-marketGlobal Medical Cannabis Market Scope and Market SizeMedical cannabis market is segmented of the basis of species, derivatives, application and route of administration. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.Based on species, the medical cannabis market is segmented into cannabis indica, sativa and hybrid.Derivatives segment of the medical cannabis market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC), and others.The application segment of the medical cannabis market is divided into pharmaceutical industry, research and development centers and others.Based on route of administration, the medical cannabis market is bifurcated into oral solutions and capsules, smoking, vaporizers, topicals and others.This Medical Cannabis Market Research/analysis Report Contains Answers to your following Questions1. Which Manufacturing Technology is used for Medical Cannabis? What Developments Are Going On in That Technology? Which Trends Are Causing These Developments?
2. Who Are the Global Key Players in This Medical Cannabis Market? What is Their Company Profile, Their Product Information, and Contact Information?
3. What Was Global Market Status of Medical Cannabis Market? What Was Capacity, Production Value, Cost and PROFIT of Medical Cannabis Market?
4. What Is Current Market Status of Medical Cannabis Industry? What’s Market Competition in This Industry, Both Company, and Country Wise? What’s Market Analysis of Medical Cannabis Market by Taking Applications and Types in Consideration?
5. What Are Projections of Global Medical Cannabis Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?
6. What Is Medical Cannabis Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
7. What Is Economic Impact On Medical Cannabis Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
8. What Are Market Dynamics of Medical Cannabis Market? What Are Challenges and Opportunities?
9. What Should Be Entry Strategies, Countermeasures to Economic Impact, Marketing Channels for Medical Cannabis Industry?
Still want to know more details Speak to Report Author @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-medical-cannabis-marketStrategic Points Covered in Table of Content of Global Medical Cannabis Market:1. Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Medical Cannabis market
2. Chapter 2: Exclusive Summary – the basic information of the Medical Cannabis Market.
3. Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Medical Cannabis
4. Chapter 4: Presenting the Medical Cannabis Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
5. Chapter 5: Displaying market size by Type, End User and Region 2010-2019
6. Chapter 6: Evaluating the leading manufacturers of the Medical Cannabis market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
7. Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2020-2027).
8. Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
9. Finally, Medical Cannabis Market is a valuable source of guidance for individuals and companies in decision framework.
Download Free Table of Content along with List of Tables and Figures @ https://www.databridgemarketresearch.com/toc/?dbmr=global-medical-cannabis-marketThanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.Top Trending Related Reports:
                                    
Legal Marijuana Market Size, Global Industry Growth, Statistics, COVID-19 Trends, Revenue Analysis 2020, Top Companies: VIVO Cannabis, Dr. Hemp Me, QC Infusion, Green Roads, Royal CBD, HempLife Today, Hemp Oil Canada
CBD Oil Market Size 2020-Industry Share, Growth, COVID-19 Trends, Revenue Analysis, Top Leaders-Dr. Hemp Me, Green Roads, Royal CBD, Healthcare Advertising Europe, King CBD: Says DBMR AnalystGlobal CBD Oil Extract Market Size, Share, Growth, Industry By Source Type (Hemp, Marijuana), Distribution Channel (B2B, B2C), End Use (Medical, Personal use, Pharmaceutical, Wellness), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027. Read More @ https://www.databridgemarketresearch.com/reports/global-cbd-oil-extract-marketGlobal CBD Edibles Market Size, Share, Growth, Industry By Source Type (Hemp, Marijuana), Application (Personal Care & Cosmetics, Pharmaceutical, Food & Beverage, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027. Read More @ https://www.databridgemarketresearch.com/reports/global-cbd-edibles-marketGlobal CBD Infused Edible Market Size, Share, Growth, Industry By Source (Hemp, Marijuana), Form (Process Oil, Distillate, Isolate), Grade (Food, Therapeutic), Application (Food & Beverage, Cosmetic & Personal Care, Pharmaceutical, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027. Read More @ https://www.databridgemarketresearch.com/reports/global-cbd-infused-edible-marketGlobal CBD Patch Market Size, Share, Growth, Industry By Type (Layer Drug-in-Adhesive, Reservoir, Others), Application (Chronic Pain, Elevate Mood, Anxiety, Others), Distribution Channel (Conventional Stores, Online Stores, Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027Global Cannabis Capsule Market Size, Share, Growth, Industry By Product (High THC Capsule, THC/CBD Balanced Capsules, High CBD Capsules Digital), Compound (Tetrahydrocannabinol (THC)-Dominant, Cannabidiol (CBD)-Dominant), Application (Medical, Recreational), End User (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Sales), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027Global Cannabis Seeds Market Size, Share, Growth, Industry By Type (Whole Cannabis Seeds, Shelled Cannabis Seeds, Cannabis Seeds Oil, Cannabis Seeds Protein), Application (Personal Care Products, Pharmaceuticals), Source (Organic, Conventional), Distribution Channel (Direct Sales, Online, Modern Trade Format, Convenience Stores, Departmental Stores, Retails and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027.Global Hemp-based Foods Market Size, Share, Growth, Industry By Product Type (Hemp Seed Oil, Hemp Protein Powder, Whole Hemp Seed, Hulled Hemp Seed, Others),  Distribution Channel (Supermarket Stores, Convenience Stores, Hypermarket Stores, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027. Read More @https://www.databridgemarketresearch.com/reports/global-hemp-based-foods-marketGlobal Cannabis Infused Products Market Size, Share, Growth, Industry By Product (Skincare, Cosmetics, Haircare, Intimate Lubricants, Pharmaceuticals, Gummies, Pills, Infused Beverages, and Other), Source (Hemp, Marijuana), Distribution Channel (B2B, B2C), End User (Medical, Personal Use, Pharmaceuticals, Wellness), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends & Forecast to 2027. Read More @ https://www.databridgemarketresearch.com/reports/global-cannabis-infused-products-marketAbout Data Bridge Market Research:An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client-satisfying rate.Contact Us:                        
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475        
E-Mail: corporatesales@databridgemarketresearch.com

Cannabis

Benchmark Provides Update on Financial Condition of Potanicals

Newsfile

Published

on

Vancouver, British Columbia–(Newsfile Corp. – October 23, 2020) – Benchmark Botanics, Inc. (CSE: BBT) (“Benchmark” or the “Company”) Benchmark announces that the ongoing working capital deficiency of Potanicals Green Growers Inc. (“Potanicals“), the Company’s wholly owned subsidiary, may result in Potanicals being unable to meet all of its accounts payable at October 31, 2020, including its October 31, 2020 payroll obligations for all 39 of Potanicals’ employees, which will cause material uncertainty about Potanicals’ ability to continue as a going concern. During the period from January 1, 2019 to December 31, 2019, Potanicals had a net loss of approximately $1,736,000. As at October 22, 2020, Potanicals had cash of $102,493, and a working capital deficiency of $134,605.

The Company is actively exploring various options to address the financial difficulty issues of Potanicals, including increasing its sales from inventory, cutting its costs, restructuring its operations, and undertaking an equity or debt financing. To meet such funding requirements, if the Company closes an additional equity financing, it would be dilutive to existing shareholders. Debt financing, if available, may also involve restrictions on financing and operating activities. There is no assurance that such additional financing will be available on terms acceptable to the Company or at all. If the Company is unable to obtain additional financing as needed, it may be required to reduce the scope of the operations of Potanicals or any planned expansion. No assurances can be given that the Company will be able to raise the additional funding that may be required for such activities. The Company will provide further updates on this matter as it develops.

About Benchmark

Benchmark is a diversified multi-licensed cannabis producer focused on a three-way vertical business model targeting the medical and recreational markets in Canada. The Company’s business plan also includes a strategy to become a Canadian licensed producer to pioneer selling medical cannabis and hemp throughout Asia, in countries where it is legal to do so.

Benchmark is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint.

Benchmark’s 100% owned subsidiary, Potanicals Green Growers Inc. (“Potanicals) is a Health Canada licensed producer under the Cannabis Act and its regulations. The Company is producing at its indoor Peachland, BC Cannabis Complex and is constructing a Phase II expansion of an additional 10,000 square foot extraction facility there. Along with cultivation and production, the company’s Peachland BC facility also provides propagation, cultivation, cloning, storage, research and development, genetic improvements.

As part of its expansion strategy, the company and a joint venture partner completed a second facility, a 4-acre Greenhouse Operation in Pitt Meadows, BC. The Company, through Potanicals, has received its second cultivation license, effective November 29, 2019, from Health Canada for the Pitt Meadow greenhouse.

For further information, please visit the Company’s website at www.benchmarkbotanics.com or the Company’s profile at www.sedar.com.

If you would like to be added to Benchmark’s news distribution list, please sign up at Investor Relations info@bbtinc.ca.

ON BEHALF OF THE BOARD OF

BENCHMARK BOTANICS INC.
“William Ying”

William Ying
Chief Executive Officer

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

Forward-Looking Statements

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/66763

Continue Reading

Cannabis

PURA Addresses Next Steps to Issue Dividend of PAOG Stock

Newsfile

Published

on

Dallas, Texas–(Newsfile Corp. – October 23, 2020) – Puration, Inc. (OTC Pink: PURA) today announced that PURA management and PAO Group, Inc. (OTC Pink: PAOG) management have scheduled combined efforts next week to complete the joint documentation and submission requirements necessary to execute the planned dividend of PAOG stock to PURA shareholders. A joint PURA and PAOG announcement is scheduled for next Friday, October 30, 2020. The dividend update announcement comes today in conjunction with the overall corporate update scheduled for release today and included in its entirety below:

Corporate Update

Last month, PURA introduced Farmersville Brands and announced a major juncture in the company’s growth and development as the company pivots from its hemp derived CBD beverage industry foundation to launch a Texas flavored, holistic lifestyle branded approach into a broader, but still niche, $20 billion sector within an overall market worth at least $2 trillion.

January of this year, PURA launched an acquisition campaign as a forerunner initiative to the Farmersville Brands transition.

Since launching the acquisition campaign in January, the company has acquired a CBD confections business, a CBD pet products business and CBD sun care business. Combined with its existing beverage industry product line, PURA’s combined horizontal market opportunity ranges across over $2 trillion in market value:

Sexual wellness $39 Billion Projected Market Value

Confections $232 Billion Projected Market Value

Pet Products $202 Billion Projected Market Value

Sun Care $12.6 Billion Projected Market Value

Non-Alcoholic Beverage $1.6 Trillion Projected Market Value

Central to the Farmersville Brands transition is the construction of a lifestyle brand that embodies the values, interests, attitudes, and opinions of the population where CBD and hemp products are an ideal fit.

Farmersville Brands holistic lifestyle approach will include a certain Texas personality component built on a targeted 72-acre property in Farmersville, Texas, just north of Dallas, expected to soon be acquired by PURA.

The location is intended to be a hemp mecca were visitors can participate in and learn about the reintroduction of hemp into the American market. Visitors can engage on a recreational weekend sojourn, or engage in a professional capacity to explore the best agricultural and processing practices, and new innovative methods for utilizing hemp to construct homes or to power cars.

Earlier this week, on Wednesday, PURA announced executing a contract to purchase the 72-acre farmland parcel located in Farmersville, TX, for a consideration of $1.3 million. This is a key step in the Farmersville Brand strategy transition.

PURA also has a planned $100 million investment strategy developing to fund the Farmersville transition. The company is keeping details under wraps at the moment but anticipates making the plan pubic before year end.

PAOG Dividend Next Steps

PAO Group, inc. (OTC Pink: PAOG) recently acquired a hemp cultivation business from PURA. PAOG is building a partnership with PURA in conjunction with PAOG’s new hemp cultivation business. PAOG has announced working with PURA’s new hemp processing facility in Farmersville, Texas where the two companies will partner on the construction of a greenhouse for cultivating pharmaceutical grade hemp and a lab for CBD extraction.

PAOG’s partnership includes making PURA shareholders, shareholders of PAOG. PAOG’s purchase of PURA included a PAOG stock issued to PURA shareholders in a dividend distribution. The timing of the execution of the dividend has been impacted by PAOG’s overall large volume of work surrounding the integration of its recently acquired RespRx CBD treatment for Chronic Obstructive Pulmonary Disease (COPD) and its newly acquired hemp cultivation operations. PAOG and PURA management have committed time together next week to get the dividend process over the speed bump. A joint progress announcement is planned for a week from today, next Friday, October 30, 2020.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/66751

Continue Reading

Cannabis

PAOG Signs Clinical Research Organization (CRO) to Advance Respiratory Cannabis Treatment Through Regulatory Approval

Newsfile

Published

on

Sandusky, Ohio–(Newsfile Corp. – October 23, 2020) – PAO Group, Inc. (OTC Pink: PAOG) today announced executing a master services agreement with a clinical research organization in the U.S. to prepare PAOG for initiating an investigational New Drug application (IND) with the Food and Drug Administration (FDA). PAOG signed the agreement yesterday, prior to the comprehensive corporate update scheduled for publication today and included in its entirety below.

Corporate Update

Less than 90 days ago, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY) and began to transform the company into a cannabis biopharmaceutical development operation. The company has come a long way very quickly and management believes the rapid progress has been possible based on the merits of the research backing RespRx.

RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disease (COPD) derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled, “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT”.

In an initial scientific evaluation as a treatment for COPD, RespRx has demonstrated affecting significant increases in respiration rate, tidal volume and inspiratory air flow rate. Overall data from the evaluation demonstrated that RespRx can significantly improve inspiratory lung functions in instances of moderate pulmonary fibrosis.

The CRO agreement signed yesterday is a year long agreement and a major step forward to advancing RespRx through the regulatory approval process. PAOG plans to make a joint announcement next week with the CRO company.

As previously announced, and in addition to the CRO agreement announced today, PAOG continues to develop pharmaceutical research and development relationships in Puerto Rico’s burgeoning, recently reinvigorated pharmaceutical industry. An announcement of an anticipated key contract in Puerto Rico is expected soon.

Part of PAOG’s pharmaceutical development strategy includes the development of a proprietary hemp cultivar. In addition to acquiring RespRx from KALY, PAOG recently acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA). PAOG is building a partnership with PURA in conjunction with PAOG’s new hemp cultivation business. PAOG has announced working with PURA’s new hemp processing facility in Farmersville, Texas where the two companies will partner on the construction of a greenhouse for cultivating pharmaceutical grade hemp and a lab for CBD extraction.

PAOG’s partnership includes making PURA shareholders, shareholders of PAOG. PAOG’s purchase of PURA included a PAOG stock issued to PURA shareholders in a dividend distribution. The timing of the execution of the dividend has been impacted by the overall large volume of work surrounding the integration of the RespRx and hemp cultivation operations and the prioritization of establishing a CRO contract. PAOG and PURA management have committed time together next week to get the dividend process over the speed bump. A joint progress announcement is planned for a week from today, next Friday, October 30, 2020.

www.paogroupinc.com

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

CONTACT INFORMATION:

Jim DiPrima
888-272-6472
info@pao.group

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/66743

Continue Reading

Trending Online

Grassnews is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Grassnews digests / hand picks the latest news about the CBD / Legal Cannabis industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Grassnews .com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania